Federal Register / Vol. 86, No. 150 / Monday, August 9, 2021 / Notices 43561 

Information 

collection forms 

Number of 

respondents 

Number of 

responses 

per 

respondent 

Average 

burden per 

response 

(in hours) 

Total annual 

burden hours 

Data Tables ..................................................................................................... 1,515 1 4 6,060

PHS 398 Career Development Award Supplemental Form ............................ 2,251 1 10 22,510 

PHS Human Subjects and Clinical Trial Information ....................................... 54,838 1 13 712,894 

Biosketch (424 Electronic) ............................................................................... 80,946 1 2 161,892 

PHS Fellowship Supplemental Form (includes F reference letters) ............... 6,707 1 12.5 83,838 

Biosketch (Fellowship) ..................................................................................... 6,707 1 2 13,414 

416–1 ............................................................................................................... 29 1 10 290

PHS 416–5 ...................................................................................................... 6,707 1 5/60 559

PHS 6031 ........................................................................................................ 6,217 1 5/60 518 

VCOC Certification .......................................................................................... 6 1 5/60 1 

SBIR/STTR Funding Agreement Certification ................................................. 1,500 1 15/60 375 

Total .......................................................................................................... ........................ 413,393 ........................ 2,023,454 

Dated: July 30, 2021. 

Lawrence A. Tabak, 

Principal Deputy Director, National Institutes 

of Health. 

[FR Doc. 2021–17031 Filed 8–6–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Eunice Kennedy Shriver National 

Institute of Child Health & Human 

Development; Notice of Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the National Advisory Child 

Health and Human Development 

Council. 

The meeting will be held as a virtual 

meeting and is open to the public. 

Individuals who plan to view the virtual 

meeting and need special assistance or 

other reasonable accommodations to 

view the meeting, should notify the 

Contact Person listed below in advance 

of the meeting. The open session will be 

videocast and can be accessed from the 

NIH Videocasting and Podcasting 

website (http://videocast.nih.gov/). 

A portion of the meeting will be 

closed to the public in accordance with 

the provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Advisory 

Child Health and Human Development 

Council. 

Date: September 9–10, 2021. 

Open: September 9, 2021, 12:00 p.m. to 

5:00 p.m. 

Agenda: The agenda will include opening 

remarks, administrative matters, NICHD 

Director’s Report, and other business of the 

Council. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, C-Wing, 

Conference Room 6, Bethesda, MD 20892 

(Virtual Meeting). 

Closed: September 10, 2021, 12:00 p.m. to 

5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Building 31, 31 Center Drive, C-Wing, 

Conference Room 6, Bethesda, MD 20894 

(Virtual Meeting). 

Contact Person: Ms. Lisa Neal, Committee 

Management Officer, Committee 

Management Branch, Eunice Kennedy 

Shriver National Institute of Child Health 

and Human Development, NIH, 6701B 

Rockledge Drive, Room 2208, Bethesda, MD 

20892, (301) 204–1830, lisa.neal@nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

Individuals will be able to view the 

meeting via NIH Videocast. Select the 

following link for Videocast access 

instructions: http://www.nichd.nih.gov/ 

about/advisory/nachhd/Pages/virtualmeeting.aspx. 

Information is also available on the 

Institute’s/Center’s home page: https://

www.nichd.nih.gov/about/advisory/council, 

where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.864, Population Research; 

93.865, Research for Mothers and Children; 

93.929, Center for Medical Rehabilitation 

Research; 93.209, Contraception and 

Infertility Loan Repayment Program, National 

Institutes of Health, HHS) 

Dated: August 4, 2021. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–16914 Filed 8–6–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Substance Abuse and Mental Health 

Services Administration 

Meeting of the Substance Abuse and 

Mental Health Services 

Administration’s National Advisory 

Council 

AGENCY: Substance Abuse and Mental 

Health Services Administration, HHS. 

ACTION: Notice. 

SUMMARY: Notice is hereby given of the 

meeting on August 30, 2021 of the 

Substance Abuse and Mental Health 

Services Administration’s (SAMHSA) 

National Advisory Council (SAMHSA 

NAC). The meeting is open to the public 

and can only be accessed virtually. 

Agenda with call-in information will be 

posted on the SAMHSA website prior to 

the meeting at: https://

www.samhsa.gov/about-us/advisorycouncils/meetings. The meeting will 

include remarks and discussion with 

the new Assistant Secretary for Mental 

Health and Substance Use; updates on 

SAMHSA priorities; follow up on topics 

related to the previous SAMHSA NAC 

meeting; new grant opportunities and 

initiatives, and a council discussion on 

clinical trends and emerging national 

issues with SAMHSA NAC members. 

DATES: August 30, 2021, 1:00 p.m. to 

approximately 5:00 p.m. (EDT)/Open. 

ADDRESSES: The meeting will be held 

virtually. 

FOR FURTHER INFORMATION CONTACT: 

Carlos Castillo, Committee Management 


lotter on DSK11XQN23PROD with NOTICES1
43562 Federal Register / Vol. 86, No. 150 / Monday, August 9, 2021 / Notices 

Officer and Designated Federal Official, 

SAMHSA National Advisory Council, 

5600 Fishers Lane, Rockville, Maryland 

20857 (mail), Telephone: (240) 276– 

2787, Email: carlos.castillo@

samhsa.hhs.gov. 

SUPPLEMENTARY INFORMATION: The 

SAMHSA NAC was established to 

advise the Secretary, Department of 

Health and Human Services (HHS), and 

the Assistant Secretary for Mental 

Health and Substance Use, SAMHSA, to 

improve the provision of treatments and 

related services to individuals with 

respect to substance use and to improve 

prevention services, promote mental 

health, and protect legal rights of 

individuals with mental illness and 

individuals who are substance users. 

Interested persons may present data, 

information, or views orally or in 

writing, on issues pending before the 

Council. Written submissions must be 

forwarded to the contact person no later 

than seven days before the meeting. Oral 

presentations from the public will be 

scheduled at the conclusion of the 

meeting. Individuals interested in 

making oral presentations must notify 

the contact person by August 23, 2021. 

Up to three minutes will be allotted for 

each presentation, and as time permits. 

To obtain the call-in number, access 

code, and/or web access link; submit 

written or brief oral comments; or 

request special accommodations for 

persons with disabilities, please register 

on-line at: https://

snacregister.samhsa.gov/ 

MeetingList.aspx, or communicate with 

SAMHSA’s Committee Management 

Officer, CAPT Carlos Castillo. 

Meeting information and a roster of 

Council members may be obtained 

either by accessing the SAMHSA 

Council’s website at http://

www.samhsa.gov/about-us/advisorycouncils/, or by contacting Carlos 

Castillo. 

Council Name: Substance Abuse and 

Mental Health Services Administration, 

National Advisory Council. 

Authority: Public Law 92–463. 

Dated: July 30, 2021. 

Carlos Castillo, 

Committee Management Officer, SAMHSA. 

[FR Doc. 2021–16891 Filed 8–6–21; 8:45 am] 

BILLING CODE 4162–20–P 

DEPARTMENT OF THE INTERIOR 

Fish and Wildlife Service 

[Docket No. FWS–R3–ES–2020–0111; 

FXES11130300000–201–FF03E00000] 

Endangered and Threatened Wildlife 

and Plants; Draft Recovery Plan for the 

Poweshiek Skipperling 

AGENCY: Fish and Wildlife Service, 

Interior. 

ACTION: Notice of availability and 

request for public comment. 

SUMMARY: We, the U.S. Fish and 

Wildlife Service, announce the 

availability of the draft recovery plan for 

the Poweshiek skipperling, a butterfly 

species. We request review and 

comment on this draft recovery plan 

from local, State, and Federal agencies, 

and the public. 

DATES: We must receive comments by 

September 8, 2021. 

ADDRESSES: 

Document availability: The draft 

recovery plan, along with any comments 

and other materials that we receive, will 

be available for public inspection at 

http://www.regulations.gov in Docket 

No. FWS–R3–ES–2020–0111. 

Submitting Comments: You may 

submit comments by one of the 

following methods: 

• Internet: http://

www.regulations.gov. Search for and 

submit comments on Docket No. FWS– 

R3–ES–2020–0111. 

• U.S. mail: Public Comments 

Processing, Attn: Docket No. FWS–R3– 

ES–2020–0111; U.S. Fish and Wildlife 

Service Headquarters, MS: PRB/3W; 

5275 Leesburg Pike; Falls Church, VA 

22041–3803. 

For more information, see Availability 

of Public Comments under 

SUPPLEMENTARY INFORMATION. 

FOR FURTHER INFORMATION CONTACT: 

Shauna Marquardt, by phone at 952– 

252–0092, via email at shauna_

marquardt@fws.gov, or via the Federal 

Relay Service at 800–877–8339. 

SUPPLEMENTARY INFORMATION: We, the 

U.S. Fish and Wildlife Service (Service), 

announce the availability of the draft 

recovery plan for the endangered 

Poweshiek skipperling (Oarisma 

poweshiek) for public review and 

comment. The Poweshiek skipperling is 

a small prairie butterfly most often 

found in remnants of native prairies and 

fens. The draft recovery plan includes 

objective, measurable criteria and 

management actions as may be 

necessary for removal of the species 

from the Federal List of Endangered and 

Threatened Wildlife. We request review 

and comment on this draft recovery 

plan from local, State, and Federal 

agencies, and the public. 

Recovery Planning 

Section 4(f) of the Endangered Species 

Act of 1973, as amended (Act; 16 U.S.C. 

1531 et seq.), requires the development 

of recovery plans for listed species, 

unless such a plan would not promote 

the conservation of a particular species. 

Also pursuant to section 4(f) of the Act, 

a recovery plan must, to the maximum 

extent practicable, include (1) a 

description of site-specific management 

actions as may be necessary to achieve 

the plan’s goals for the conservation and 

survival of the species; (2) objective, 

measurable criteria that, when met, 

would support a determination under 

section 4(a)(1) that the species should be 

removed from the List of Endangered 

and Threatened Species; and (3) 

estimates of the time and costs required 

to carry out those measures needed to 

achieve the plan’s goal and to achieve 

intermediate steps toward that goal. 

Species Background 

The Poweshiek skipperling once 

ranged throughout the upper Midwest, 

from Illinois and Iowa in the south, to 

Michigan in the east, to North Dakota 

and South Dakota in the west, and 

southern Manitoba in the north. 

Currently, populations of the Poweshiek 

skipperling are known to occur in 

Michigan and Manitoba, Canada, and 

possibly in Wisconsin. 

It is not known exactly what led to the 

decline in the species; however, 

populations are likely influenced by 

degradation and destruction of habitat 

through conversion of native prairie to 

cropland or development; ecological 

succession to woody vegetation; 

encroachment of invasive species; past 

and present fire, haying, or grazing 

management that degraded or destroyed 

the species’ habitats; flooding; and, 

groundwater depletion, alteration, and 

contamination. Additionally, biocide 

use may have direct or indirect effects 

on Poweshiek skipperlings, 

compounding the effects of habitat 

curtailment. The remaining populations 

of the Poweshiek skipperling are small 

and isolated, and thus they are 

vulnerable to the effects of small 

population dynamics, further 

compounding the effects of other 

stressors. 

Under the Act, the Service added the 

Poweshiek skipperling to the Federal 

List of Endangered and Threatened 

Wildlife as an endangered species on 

October 23, 2014 (79 FR 63671). 


lotter on DSK11XQN23PROD with NOTICES1